Erratum: 3-Yr Follow-up of Topical Corticosteroid Treatment for Eosinophilic Esophagitis in Adults

2010 ◽  
Vol 105 (10) ◽  
pp. 2308
Author(s):  
Emelie F Helou ◽  
Julie Simonson ◽  
Amindra S Arora
Keyword(s):  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Corticosteroid Treatment

scholarly journals Clinical Outcome of Hypertensive Uveitis

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Deborah Lewkowicz ◽  
François Willermain ◽  
Lia Judice Relvas ◽  
Dorine Makhoul ◽  
Sarah Janssens ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Surgical Treatment ◽  
Clinical Outcome ◽  
Topical Corticosteroid ◽  
Retrospective Review ◽  
Corticosteroid Treatment ◽  
First Episode ◽  
Elevated Intraocular Pressure ◽  
Unilateral Disease

Purpose. To review the clinical outcome of patients with hypertensive uveitis.Methods. Retrospective review of uveitis patients with elevated intraocular pressure (IOP) > 25 mmHg and >1-year follow-up. Data are uveitis type, etiology, viral (VU) and nonviral uveitis (NVU), IOP, and medical and/or surgical treatment.Results. In 61 patients, IOP values are first 32.9 mmHg (SD: 9.0), highest 36.6 mmHg (SD: 9.9), 3 months after the first episode 19.54 mmHg (SD: 9.16), and end of follow-up 15.5 mmHg (SD: 6.24). Patients with VU (n=25) were older (50.6 y/35.7 y,p=0.014) and had more unilateral disease (100%/72.22%  p=0.004) than those with NVU (n=36). Thirty patients (49.2%) had an elevated IOP before topical corticosteroid treatment. Patients with viral uveitis might have higher first elevated IOP (36.0/27.5 mmHg,p=0,008) and maximal IOP (40.28/34.06 mmHg,p=0.0148) but this was not significant when limited to the measurements before the use of topical corticosteroids (p=0.260and 0.160). Glaucoma occurred in 15 patients (24.59%) and was suspected in 11 (18.03%) without difference in viral and nonviral groups (p=0.774).Conclusion. Patients with VU were older and had more unilateral hypertensive uveitis. Glaucoma frequently complicates hypertensive uveitis. Half of the patients had an elevated IOP before topical corticosteroid treatment.

1001 A Multivariable Model Predicts Complete Histologic Response to Topical Corticosteroid Treatment in Eosinophilic Esophagitis

2017 ◽  
Vol 85 (5) ◽  
pp. AB121
Author(s):  
Swathi Eluri ◽  
Irina Perjar ◽  
Johnathan Hollyfield ◽  
Spencer Rusin ◽  
John T. Woosley ◽  
...  
Keyword(s):  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Corticosteroid Treatment ◽  
Multivariable Model ◽  
Histologic Response

Topical Corticosteroid Treatment of Dysphagia Due to Eosinophilic Esophagitis in Adults

2003 ◽  
Vol 78 (7) ◽  
pp. 830-835 ◽  
Author(s):  
Amindra S. Arora ◽  
Jean Perrault ◽  
Thomas C. Smyrk
Keyword(s):  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Corticosteroid Treatment

scholarly journals Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids

2021 ◽  
Vol 10 (6) ◽  
pp. 1309
Author(s):  
Hye Young Han ◽  
Ki Cheol Park ◽  
Eun-Ae Yang ◽  
Kyung-Yil Lee
Keyword(s):  
Mycoplasma Pneumoniae ◽  
Serological Test ◽  
Corticosteroid Treatment ◽  
23S Rrna ◽  
Laboratory Parameters ◽  
The Mean ◽  
Domain V ◽  
Positive Results ◽  
Mycoplasma Pneumoniae Pneumonia

We have found that early corticosteroid therapy was effective for reducing morbidity during five Korea-wide epidemics. We evaluated the clinical and laboratory parameters of 56 children who received early corticosteroid treatment for pneumonia that was caused by macrolide-resistant Mycoplasma pneumoniae (M. pneumoniae) or macrolide-sensitive M. pneumoniae between July 2019 and February 2020. All subjects had dual positive results from a PCR assay and serological test, and received corticosteroids within 24–36 h after admission. Point mutation of residues 2063, 2064, and 2067 was identified in domain V of 23S rRNA. The mean age was 6.8 years and the male:female ratio was 1.2:1 (31:25 patients). Most of the subjects had macrolide-resistant M. pneumoniae (73%), and all mutated strains had the A2063G transition. No significant differences in clinical and laboratory parameters were observed between macrolide-resistant and macrolide-sensitive M. pneumoniae groups that were treated with early dose-adjusted corticosteroids. Higher-dose steroid treatment may be needed for patients who have fever that persists for >48 h or increased biomarkers such as lactate dehydrogenase concentration at follow-up despite a usual dose of steroid therapy.

Sign in / Sign up

Export Citation Format

Share Document